Nirvana Life Sciences Inc. (CSE:NIRV)
Canada · Delayed Price · Currency is CAD 0.0700
0.00 (0.00%)
At close: Jan 26, 2026
Nirvana Life Sciences Market Cap
Nirvana Life Sciences has a market cap or net worth of CAD 1.6 million as of February 9, 2026. Its market cap has decreased by -83.16% in one year.
Market Cap
1.60M
Enterprise Value
1.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since March 17, 2022, Nirvana Life Sciences's market cap has decreased from 4.27M to 1.60M, a decrease of -62.41%. That is a compound annual growth rate of -22.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 1.60M | -6.67% |
| Dec 29, 2025 | 1.72M | -28.71% |
| Dec 27, 2024 | 2.41M | 150.00% |
| Dec 28, 2023 | 964.66K | -81.10% |
| Dec 19, 2022 | 5.10M | 19.58% |
| Mar 17, 2022 | 4.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gemina Laboratories | 4.59M |
| XORTX Therapeutics | 4.04M |
| MindBio Therapeutics | 3.84M |
| Rakovina Therapeutics | 3.60M |
| Appili Therapeutics | 3.21M |
| ASEP Medical Holdings | 3.00M |
| Algernon Health | 2.36M |
| Universal Ibogaine | 1.56M |